News and Trends 19 Oct 2022
Nucleome Therapeutics raises £37.5M to deliver precision medicines
…human genome into useful drug discovery insights. Auto-immune disease targets Nucleome’s platform combines 3D genome technology and machine learning to shed light on these variants by directly linking genes to…